{"text": "launches with tech that custom engineers crispr molecules for in vivo geneediting therapies that offer better efficacy safety amp delivery the biotech startup already has a partnership with developing a therapy for als biib"}
{"text": "biib below avg volume daily appearances since 2010 282 close 5 days later avg 0 96 sd 9 76 worst 36 18 best 50 59 10 days later avg 1 90 sd 14 54 worst 33 96 best 65 00 30 days later avg 2 64 sd 25 30 worst 103 76 best 58 17"}
{"text": "biogen gene editing startup scribe to develop therapies for lou gehrig s disease biib crsp"}
{"text": "cognitive outcomes are also limited by prev brain structures not just modified impacted damaged by neurodiseases biib yes i still have hopes for the company not for a aducanumab but the company"}
{"text": "biib biogen and scribe therapeutics inc announce research collaboration to develop and commercialize crispr based"}
{"text": "the professor s latest company said tuesday that it landed a deal with biib"}
